Keyphrases
Head-and-neck
100%
Transcription Factor
100%
Glutathione
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Radiation Sensitivity
100%
Human Head
100%
Nuclear factor-B
100%
Cisplatin Sensitivity
100%
Human Neck
100%
Cisplatin
44%
UM-SCC
33%
Molecular Determinants
22%
Chemoradiation Therapy
22%
Radiation Resistance
22%
Mitochondrial GSH
22%
SCC-9 Cells
22%
Gene Transfer
11%
Targets for Therapy
11%
Organ Preservation
11%
Patient Selection
11%
Chemotherapy Sensitivity
11%
NF-B
11%
Cisplatin-based Chemotherapy
11%
Carcinoma Cell Lines
11%
Resistant mutants
11%
Buthionine Sulfoximine
11%
Cisplatin Resistance
11%
Cytoprotective Genes
11%
Neoadjuvant Cisplatin
11%
Squamous Carcinoma Cells
11%
Degradation-resistant
11%
Cooperative Group Trial
11%
Organ Preservation Therapy
11%
Medicine and Dentistry
Neck
100%
Carcinoma
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Nuclear Factor
100%
Glutathione
100%
Transcription Factors
100%
Cisplatin
100%
Radiosensitivity
100%
Head and Neck Squamous Cell Carcinoma
70%
Chemoradiation Therapy
20%
Group Trial
10%
Gene Transfer
10%
Head and Neck Squamous Cell Carcinoma Cell Line
10%
Cytoprotective Agent
10%
Buthionine Sulfoximine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Squamous Cell Carcinoma
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Glutathione
100%
Nuclear Factor
100%
Transcription Factors
100%
Head and Neck Squamous Cell Carcinoma
80%
Chemotherapy
20%
Chemoradiation Therapy
20%
Group Trial
10%
Cytoprotective Agent
10%
Buthionine Sulfoximine
10%
Gene Delivery
10%
Immunology and Microbiology
Radioresistance
100%
Complement Factor B
100%
Neck
100%
Transcription Factors
100%
Glutathione
100%
Squamous Cell
87%
Gene Transfer
12%
Head and Neck Squamous Cell Carcinoma Cell Line
12%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
Transcription Factors
100%
Complement Factor B
100%
Radiosensitivity
100%
Glutathione
100%
Group Trial
10%
Buthionine Sulfoximine
10%